Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis.

M Schaub, Shohreh Issazadeh-Navikas, T H Stadlbauer, R Peach, M H Sayegh, S J Khoury

    Research output: Contribution to journalJournal articleResearchpeer-review

    36 Citations (Scopus)

    Abstract

    Blockade of the CD28-B7 or CD40L-CD40 T cell costimulatory signals prevents induction of experimental autoimmune encephalomyelitis (EAE). However, the effect of simultaneous blockade of these signals in EAE is unknown. We show that administration of either MR1 (to block CD40L) or CTLA4Ig (to block B7) after immunization or after the first attack protects from EAE. Treatment with a combination of CTLA4Ig and MR1 provides additive protection, and is associated with complete absence of mononuclear cell infiltrates in the central nervous system, and marked suppression of proliferation of primed T cells in the periphery. Selective B7-1 blockade did not protect from EAE. These observations have implications for therapy of autoimmune diseases.
    Original languageEnglish
    JournalJournal of Neuroimmunology
    Volume96
    Issue number2
    Pages (from-to)158-66
    Number of pages8
    ISSN0165-5728
    Publication statusPublished - 1999

    Bibliographical note

    Keywords: Animals; Antigens, CD; Antigens, CD28; Antigens, CD80; Antigens, Differentiation; CD40 Ligand; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Female; Immunoconjugates; Immunosuppressive Agents; Membrane Glycoproteins; Mice; Myelin Basic Proteins; Recurrence; Signal Transduction; T-Lymphocytes; Time Factors

    Cite this